LISBON, Portugal--(BUSINESS WIRE)--At the 32 nd European Congress of Clinical Microbiology & Infectious Diseases (www.eccmid.org), Bruker Corporation (Nasdaq: BRKR) announces further advances in its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback